The role of focal adhesion kinase catalytic activity on the proliferation and migration of squamous cell carcinoma cells

International Journal of Cancer

Volumn 131, Issue 2, 2012, Pages 287-297

  Serrels, Alan ^a   McLeod, Kenneth ^a   Canel, Marta ^a   Kinnaird, Andrew ^a   Graham, Kathryn ^b   Frame, Margaret C ^a   Brunton, Valerie G ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

FAK; proliferation; Src; tumour cell migration

Indexed keywords

FOCAL ADHESION KINASE; PF 562271; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL ASSAY; CELL MIGRATION; CELL POLARITY; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; IMAGE ANALYSIS; IMAGE DISPLAY; IN VIVO STUDY; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; THREE DIMENSIONAL IMAGING; TUMOR XENOGRAFT; WILD TYPE;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL MOVEMENT; CELL POLARITY; CELL PROLIFERATION; FOCAL ADHESION PROTEIN-TYROSINE KINASES; INDOLES; MICE; MICE, TRANSGENIC; PROTEIN KINASE INHIBITORS; PYRIMIDINES; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; SULFONAMIDES; THIAZOLES;

EID: 84861637416     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26351     Document Type: Article

References (48)

1. Ilic D, Furuta Y, Kanazawa S, Takeda N, Sobue K, Nakatsuji N, Nomura S, Fujimoto J, Okada M, Yamamoto T,. Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 1995; 377: 539-44.
2. Sieg DJ, Hauck CR, Schlaepfer DD,. Required role of focal adhesion kinase (FAK) for integrin-stimulated cell migration. J Cell Sci 1999; 112: 2677-91.
3. Hauck CR, Sieg DJ, Hsia DA, Loftus JC, Gaarde WA, Monia BP, Schlaepfer DD,. Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells. Cancer Res 2001; 61: 7079-90.
4. Sieg DJ, Hauck CR, Ilic D, Klingbeil CK, Schaefer E, Damsky CH, Schlaepfer DD,. FAK integrates growth-factor and integrin signals to promote cell migration. Nat Cell Biol 2000; 2: 249-56.
5. Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE,. Focal adhesion kinase gene silencing promotes anoikis and suppresses metastasis of human pancreatic adenocarcinoma cells. Surgery 2004; 135: 555-62.
6. Frisch SM, Vuori K, Ruoslahti E, Chan-Hui PY,. Control of adhesion-dependent cell survival by focal adhesion kinase. J Cell Biol 1996; 134: 793-9.
7. Hungerford JE, Compton MT, Matter ML, Hoffstrom BG, Otey CA,. Inhibition of pp125FAK in cultured fibroblasts results in apoptosis. J Cell Biol 1996; 135: 1383-90.
8. Zhang Y, Lu H, Dazin P, Kapila Y,. Squamous cell carcinoma cell aggregates escape suspension-induced, p53-mediated anoikis: fibronectin and integrin alphav mediate survival signals through focal adhesion kinase. J Biol Chem 2004; 279: 48342-9.
9. Xu LH, Yang X, Craven RJ, Cance WG,. The COOH-terminal domain of the focal adhesion kinase induces loss of adhesion and cell death in human tumor cells. Cell Growth Differ 1998; 9: 999-1005.
10. McLean GW, Komiyama NH, Serrels B, Asano H, Reynolds L, Conti F, Hodivala-Dilke K, Metzger D, Chambon P, Grant SG, Frame MC,. Specific deletion of focal adhesion kinase suppresses tumor formation and blocks malignant progression. Genes Dev 2004; 18: 2998-3003.
11. Lahlou H, Sanguin-Gendreau V, Zuo D, Cardiff RD, McLean GW, Frame MC, Muller WJ,. Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression. Proc Natl Acad Sci USA 2007; 104: 20302-7.
12. Luo M, Fan H, Nagy T, Wei H, Wang C, Liu S, Wicha MS, Guan JL,. Mammary epithelial-specific ablation of the focal adhesion kinase suppresses mammary tumorigenesis by affecting mammary cancer stem/progenitor cells. Cancer Res 2009; 69: 466-74.
13. Provenzano PP, Inman DR, Eliceiri KW, Beggs HE, Keely PJ,. Mammary epithelial-specific disruption of focal adhesion kinase retards tumor formation and metastasis in a transgenic mouse model of human breast cancer. Am J Pathol 2008; 173: 1551-65.
14. Pylayeva Y, Gillen KM, Gerald W, Beggs HE, Reichardt LF, Giancotti FG,. Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling. J Clin Invest 2009; 119: 252-66.
15. Slack-Davis JK, Hershey ED, Theodorescu D, Frierson HF, Parsons JT,. Differential requirement for focal adhesion kinase signaling in cancer progression in the transgenic adenocarcinoma of mouse prostate model. Mol Cancer Ther 2009; 8: 2470-7.
16. Gabarra-Niecko V, Schaller MD, Dunty JM,. FAK regulates biological processes important for the pathogenesis of cancer. Cancer Metastasis Rev 2003; 22: 359-74.
17. Siesser PM, Hanks SK,. The signaling and biological implications of FAK overexpression in cancer. Clin Cancer Res 2006; 12: 3233-7.
18. van Nimwegen MJ, van de Water B,. Focal adhesion kinase: a potential target in cancer therapy. Biochem Pharmacol 2007; 73: 597-609.
19. McLean GW, Carragher NO, Avizienyte E, Evans J, Brunton VG, Frame MC,. The role of focal-adhesion kinase in cancer - a new therapeutic opportunity. Nat Rev Cancer 2005; 5: 505-15.
20. Brunton VG, Frame MC,. Src and focal adhesion kinase as therapeutic targets in cancer. Curr Opin Pharmacol 2008; 8: 427-32.
21. Roberts WG, Ung E, Whalen P, Cooper B, Hulford C, Autry C, Richter D, Emerson E, Lin J, Kath J, Coleman K, Yao L, et al. Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271. Cancer Res 2008; 68: 1935-44.
22. Cary LA, Chang JF, Guan JL,. Stimulation of cell migration by overexpression of focal adhesion kinase and its association with Src and Fyn. J Cell Sci 1996; 109: 1787-94.
23. Sonoda Y, Matsumoto Y, Funakoshi M, Yamamoto D, Hanks SK, Kasahara T,. Anti-apoptotic role of focal adhesion kinase (FAK). Induction of inhibitor-of-apoptosis proteins and apoptosis suppression by the overexpression of FAK in a human leukemic cell line, HL-60. J Biol Chem 2000; 275: 16309-15.
24. Garces CA, Kurenova EV, Golubovskaya VM, Cance WG,. Vascular endothelial growth factor receptor-3 and focal adhesion kinase bind and suppress apoptosis in breast cancer cells. Cancer Res 2006; 66: 1446-54.
25. Serrels B, Sandilands E, Serrels A, Baillie G, Houslay MD, Brunton VG, Canel M, Machesky LM, Anderson KI, Frame MC,. A complex between FAK, RACK1 and PDE4D5 controls spreading initiation and cancer cell polarity. Curr Biol 2010; 20: 1086-92.
26. Serrels B, Serrels A, Brunton VG, Holt M, McLean GW, Gray CH, Jones GE, Frame MC,. Focal adhesion kinase controls actin assembly via a FERM-mediated interaction with the Arp2/3 complex. Nat Cell Biol 2007; 9: 1046-56.
27. Serrels A, Macpherson IR, Evans TR, Lee FY, Clark EA, Sansom OJ, Ashton GH, Frame MC, Brunton VG,. Identification of potential biomarkers for measuring inhibition of Src kinase activity in colon cancer cells following treatment with dasatinib. Mol Cancer Ther 2006; 5: 3014-22.
28. Geback T, Schulz MM, Koumoutsakos P, Detmar M,. TScratch: a novel and simple software tool for automated analysis of monolayer wound healing assays. Biotechniques 2009; 46: 265-74.
29. Vichai V, Kirtikara K,. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc 2006; 1: 1112-16.
30. Sieg DJ, Ilic D, Jones KC, Damsky CH, Hunter T, Schlaepfer DD,. Pyk2 and Src-family protein-tyrosine kinases compensate for the loss of FAK in fibronectin-stimulated signaling events but Pyk2 does not fully function to enhance FAK-cell migration. EMBO J 1998; 17: 5933-47.
31. Slack-Davis JK, Martin KH, Tilghman RW, Iwanicki M, Ung EJ, Autry C, Luzzio MJ, Cooper B, Kath JC, Roberts WG, Parsons JT,. Cellular characterization of a novel focal adhesion kinase inhibitor. J Biol Chem 2007; 282: 14845-52.
32. Hiscox S, Barnfather P, Hayes E, Bramble P, Christensen J, Nicholson RI, Barrett-Lee P,. Inhibition of focal adhesion kinase suppresses the adverse phenotype of endocrine-resistant breast cancer cells and improves endocrine response in endocrine-sensitive cells. Breast Cancer Res Treat 2011; 125: 659-69.
33. Tanjoni I, Walsh C, Uryu S, Tomar A, Nam JO, Mielgo A, Lim ST, Liang C, Koenig M, Sun C, Patel N, Kwok C, et al. PND-1186 FAK inhibitor selectively promotes tumor cell apoptosis in three-dimensional environments. Cancer Biol Ther 2010; 9: 764-77.
34. Canel M, Serrels A, Miller D, Timpson P, Serrels B, Frame MC, Brunton VG,. Quantitative in vivo imaging of the effects of inhibiting integrin signaling via Src and FAK on cancer cell movement: effects on E-cadherin dynamics. Cancer Res 2010; 70: 9413-22.
35. Zhao J, Bian ZC, Yee K, Chen BP, Chien S, Guan JL,. Identification of transcription factor KLF8 as a downstream target of focal adhesion kinase in its regulation of cyclin D1 and cell cycle progression. Mol Cell 2003; 11: 1503-15.
36. Zhao J, Pestell R, Guan JL,. Transcriptional activation of cyclin D1 promoter by FAK contributes to cell cycle progression. Mol Biol Cell 2001; 12: 4066-77.
37. Ding Q, Grammer JR, Nelson MA, Guan JL, Stewart JE, Jr., Gladson CL,. p27Kip1 and cyclin D1 are necessary for focal adhesion kinase regulation of cell cycle progression in glioblastoma cells propagated in vitro and in vivo in the SCID mouse brain. J Biol Chem 2005; 280: 6802-15.
38. Shibue T, Weinberg RA,. Integrin β1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs. Proc Natl Acad Sci USA 2009; 106: 10290-5.
39. Desgrosellier JS, Barnes LA, Shields DJ, Huang M, Lau SK, Prevost N, Tarin D, Shattil SJ, Cheresh DA,. An integrin α(v)β(3)-c-Src oncogenic unit promotes anchorage-independence and tumor progression. Nat Med 2009; 15: 1163-9.
40. Schwock J, Dhani N, Cao MP, Zheng J, Clarkson R, Radulovich N, Navab R, Horn LC, Hedley DW,. Targeting focal adhesion kinase with dominant-negative FRNK or Hsp90 inhibitor 17-DMAG suppresses tumor growth and metastasis of SiHa cervical xenografts. Cancer Res 2009; 69: 4750-9.
41. Dolfi F, Garcia-Guzman M, Ojaniemi M, Nakamura H, Matsuda M, Vuori K,. The adaptor protein Crk connects multiple cellular stimuli to the JNK signaling pathway. Proc Natl Acad Sci USA 1998; 95: 15394-9.
42. Hakak Y, Martin GS,. Cas mediates transcriptional activation of the serum response element by Src. Mol Cell Biol 1999; 19: 6953-62.
43. Oktay M, Wary KK, Dans M, Birge RB, Giancotti FG,. Integrin-mediated activation of focal adhesion kinase is required for signaling to Jun NH2-terminal kinase and progression through the G1 phase of the cell cycle. J Cell Biol 1999; 145: 1461-9.
44. Cabodi S, Tinnirello A, Di Stefano P, Bisaro B, Ambrosino E, Castellano I, Sapino A, Arisio R, Cavallo F, Forni G, Glukhova M, Silengo L, et al. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis. Cancer Res 2006; 66: 4672-80.
45. Morton JP, Karim SA, Graham K, Timpson P, Jamieson N, Athineos D, Doyle B, McKay C, Heung MY, Oien KA, Frame MC, Evans TR, et al. Dasatinib inhibits the development of metastases in a mouse model of pancreatic ductal adenocarcinoma. Gastroenterology 2010; 139: 292-303.
46. Bagi CM, Roberts GW, Andresen CJ,. Dual focal adhesion kinase/Pyk2 inhibitor has positive effects on bone tumors: implications for bone metastases. Cancer 2008; 112: 2313-21.
47. Sun H, Pisle S, Gardner ER, Figg WD,. Bioluminescent imaging study: FAK inhibitor, PF-562,271, preclinical study in PC3M-luc-C6 local implant and metastasis xenograft models. Cancer Biol Ther 2010; 10: 38-43.
48. Wendt MK, Smith JA, Schiemann WP,. Transforming growth factor-β-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression. Oncogene 2010; 29: 6485-98.